- Home
- COE vs ENTA Comparison
COE vs ENTA Comparison
Compare COE & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COE
- ENTA
- Stock Information
- Founded
- COE 2011
- ENTA 1995
- Country
- COE Singapore
- ENTA United States
- Employees
- COE N/A
- ENTA N/A
- Industry
- COE Other Consumer Services
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- COE Real Estate
- ENTA Health Care
- Exchange
- COE Nasdaq
- ENTA Nasdaq
- Market Cap
- COE 177.0M
- ENTA 164.6M
- IPO Year
- COE 2016
- ENTA 2013
- Fundamental
- Price
- COE $35.33
- ENTA $8.83
- Analyst Decision
- COE
- ENTA Strong Buy
- Analyst Count
- COE 0
- ENTA 4
- Target Price
- COE N/A
- ENTA $20.75
- AVG Volume (30 Days)
- COE 14.7K
- ENTA 175.8K
- Earning Date
- COE 08-29-2025
- ENTA 08-11-2025
- Dividend Yield
- COE N/A
- ENTA N/A
- EPS Growth
- COE N/A
- ENTA N/A
- EPS
- COE N/A
- ENTA N/A
- Revenue
- COE $59,490,000.00
- ENTA $64,806,000.00
- Revenue This Year
- COE N/A
- ENTA N/A
- Revenue Next Year
- COE N/A
- ENTA $1.65
- P/E Ratio
- COE N/A
- ENTA N/A
- Revenue Growth
- COE 91.87
- ENTA N/A
- 52 Week Low
- COE $12.11
- ENTA $4.09
- 52 Week High
- COE $46.79
- ENTA $13.43
- Technical
- Relative Strength Index (RSI)
- COE 71.96
- ENTA 65.93
- Support Level
- COE $32.70
- ENTA $6.45
- Resistance Level
- COE $46.79
- ENTA $7.73
- Average True Range (ATR)
- COE 3.13
- ENTA 0.55
- MACD
- COE 0.24
- ENTA 0.17
- Stochastic Oscillator
- COE 49.54
- ENTA 90.15
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.